🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy fatty liver reversal — November 2025 Page 6

My fatty liver reversal — November 2025

rachel_ABQ Mon, Dec 15, 2025 at 11:22 AM 33 replies 1,345 viewsPage 6 of 7
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Dec 25, 2025 at 8:04 AM#26
raj_cambridge said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

Last edited: Dec 25, 2025 at 10:04 AM
34 7DebRD_ATL, KristenIndy, MarkLI_maint and 31 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Dec 25, 2025 at 10:42 PM#27

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Dec 26, 2025 at 4:42 AM
35 8ricardo_MIA, BrianDallas92, labquiet_amy and 32 others
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Dec 26, 2025 at 1:20 PM#28
NurseAsh_DET said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

36 9rachel_ABQ, traveltech_sara, AttorneyGrant and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Dec 27, 2025 at 3:58 AM#29
NurseAsh_DET said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Dec 27, 2025 at 5:58 AM
37 10Dr.PathRoch, mona_PHX, andrew_nyc and 34 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Dec 27, 2025 at 6:35 PM#30

Closing the loop on my own question.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.

Last edited: Dec 27, 2025 at 11:35 PM
9 7Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 6 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register